Lotus Pharmaceuticals Inc LTUS

$0.00 0.00 (-26.53%)

Valuation

Market cap
9,520,000
Revenue TTM
$0
Net income TTM
$-30,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
2,300
Avg volume
18,760
Day's range
$0.00 – $0.00
Shares out
2,644,516,000
Stochastic %K
32%
Beta
-1.75
Analysts
Strong Buy
Price target
—

Price

Company profile

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company was formerly known as S.E. Asia Trading, Inc. and changed its name to Lotus Pharmaceuticals, Inc. in December 2006. Lotus Pharmaceuticals, Inc. is based in Irvine, California.

Industry
Shell Companies
Sector
Financial Services
Phone
949 591 3688
Website
https://lotuspharmaceuticalsusa.com
Address
127 Leafy Twig, Irvine, United States

Latest news

No headlines yet.